Translational Lung Cancer Research

Aims & Scope

Translational Lung Cancer Research (TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012.

TLCR is indexed by SCIE, PubMed/PubMed Central, Scopus and the Chemical Abstracts Service (CAS) Databases.

It is published quarterly the first year, and published bimonthly since February 2013.

It provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer.

Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer.

TLCR is dedicated to focus on cutting-edge developments at the transition from preclinical to clinical research and thus closes the gap between “bench and bedside”.

The aim of TLCR is to provide a forum for the dissemination of original research and review articles in all areas related to lung cancer, as well as a timely platform for the exchange of key opinions between leading experts, and so to provide readers with a novel, well-organized, informative, enlightening and educational journal.

TLCR features a distinguished editorial board, which brings together a team of highly experienced specialists in lung cancer.

The diverse experience of the board members allows our editorial panel to lend their expertise to a broad spectrum of lung cancer subjects.

The entire submission and review process are managed through the OJS system, an electronic journal system which offers an efficient way and ensures a rapid turnaround of papers submitted for publication.

Articles will be published both in print and online.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.5
2024	4.00

SJR (SCImago Journal Rank)

Year	Value
2024	1.243

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	70

Journal Rank

Year	Value
2024	3353

Journal Citation Indicator

Year	Value
2024	2768

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Non-small cell lung cancer: current treatment and future advances

  Citation: 1462

  Authors: Cecilia, Shaker A.

• The epidemiology of lung cancer

  Citation: 555

  Authors: Patricia M., Carol C., Brett W., Reginald F.

• Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)

  Citation: 291

  Authors: Hiren, Mark, Christopher, Ina I. C.

• Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes

  Citation: 236

  Authors: Wei, Luc, Yu-An, Tomohiro, Mahboubeh, Victor, Hans K., Karel, Trudy G., John D., Adi F.

• Current standards for clinical management of small cell lung cancer

  Citation: 210

  Authors: Anna F., Florence K.

• Pros: Can tissue biopsy be replaced by liquid biopsy?

  Citation: 183

  Authors: Marius, Paul

• Methods of measurement for tumor mutational burden in tumor tissue

  Citation: 180

  Authors: Bárbara, Claude, Sandrine, Myriam, Isabelle, Nicky

• Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians

  Citation: 162

  Authors: Michael, Jan, Petros, Volker, Amelie, Eugen, Anna-Lena, Martina, Moritz, Jonas, Olaf, Stefan, Roland, Michael, Peter, Albrecht

• Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance

  Citation: 155

  Authors: Roberta, Paola, Marcello

• Radiomics of pulmonary nodules and lung cancer

  Citation: 152

  Authors: Ryan, Anand

---